Intelligence Platform
Patents
Browse 23 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 12286657
Methods and compositions
granted patentUS 12268749
Cell-penetrating peptides
granted patentUS 11980637
Compositions comprising nanosilica particles and their use in methods of activating T lymp
granted patentUS 11833171
Materials and methods relating to stabilised polymeric silicate compositions
granted patentUS 11684572
Methods for producing carboxylate ligand modified ferric iron hydroxide colloids and relat
granted patentUS 11567073
Receptor tyrosine kinase biomarkers
granted patentUS 11369697
Liposome nanoparticles for tumor magnetic resonance imaging
granted patentUS 11364211
Methods for selecting phosphatase selective and non-selective phosphatase inhibitors
granted patentUS 11337941
Inhibitors and their uses
granted patentUS 11331286
Inhibitors and their uses
granted patentUS 11154519
Inhibitors and their uses
granted patentUS 11007217
Compositions comprising nanosilica particles and their use in methods of activating T lymp
granted patentUS 11000502
Antimicrobial compositions comprising copper-hydroxypyrone complexes
granted patentUS 10954198
Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfoldi
granted patentUS 10898511
Materials and methods relating to stabilised polymeric silicate compositions
granted patentUS 10882895
Nucleic acid encoding angiopoietin-2 specific Tie2 receptor
granted patentUS 10722459
Methods for producing carboxylate ligand modified ferric iron hydroxide colloids and relat
granted patentUS 10596227
Polypeptide targeting to mitochondria
granted patentUS 10526297
Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfoldi
granted patentUS 10421805
Anti-hepatitis C antibodies and antigen binding fragments thereof
granted patentUS 10208100
Angiopoietin-2 specific TIE2 receptor
granted patentUS 10201499
Nanoparticle formulation
granted patentUS 10100020
Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfoldi
granted